Hearing Loss Trial, Recruiting NCT05107466 Sponsor: Dartmouth-Hitchcock Medical Center Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT05107466
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older.
  • People with some degree of hearing loss or difficulty processing sounds, ranging from mild to more severe.
  • People who are current or new patients at the Dartmouth Health Medical Center (DHMC) Otolaryngology clinic, or employees of Dartmouth College, DHMC, or the surrounding community, as permitted under COVID guidelines.

Who may not be able to join:

  • People who have a known brain condition, such as a brain tumor or a history of stroke.
  • People who have a severe neurological or neuropsychological disorder.
  • People who have a known history of seizures.
  • People who are known to be blind.
  • People who are not able to give their own informed consent to participate.
  • People under the age of 18, including infants, children, and teenagers.
  • People who are currently incarcerated.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: James E Saunders, MD, Department of Surgery, Otolaryngology section, Dartmouth Hitchcock Medical Center

Phone: 6036502054

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
28 July 2023
Est. completion
1 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Difference in mean VEP latency as measured by onset time of the P300 wave from time of stimuli presentation.; Difference in mean VEP amplitude as measured by the maximum voltage reached by the P300 wave after presentation of stimulus before returning back to zero.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov